Effect of folylpolyglutamate synthase A22G polymorphism on the risk and survival of patients with acute lymphoblastic leukemia

Oncology Letters

Volumn 8, Issue 2, 2014, Pages 731-735

  Gómez Gómez, Yazmín ^a,c   Organista Nava, Jorge ^a   Rangel Rodriguez, Carlos Alberto ^b   Illades Aguiar, Berenice ^b   Moreno Godínez, María Elena ^b   Alarcón, Luz Del Carmen Romero ^b   Leyva Vázquez, Marco Antonio ^b  

^a INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

^b Guerrero State University   (Mexico)

^c Arturo Beltrán Ortega Cancer Institute   (Mexico)

Author keywords

A22G polymorphism; Acute lymphoblastic leukemia; Folylpolyglutamate synthase; Survival

Indexed keywords

FOLYLPOLYGLUTAMATE SYNTHASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLELE; ARTICLE; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FOLYLPOLYGLUTAMATE SYNTHASE GENE; GENE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; INFANT; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; RISK FACTOR;

EID: 84902319717     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2175     Document Type: Article

References (14)

1. Daniel-Cravioto A, Gonzalez-Bonilla CR, Mejia-Arangure JM, et al: Genetic rearrangement MLL{combining long solidus overlay}AF4 is most frequent in children with acute lymphoblastic leukemias in Mexico City. Leuk Lymphoma 50: 1352-1360, 2009.
2. Mejia-Arangure J, Bonilla M, Lorenzana R, et al: Incidence of leukemias in children from El Salvador and Mexico City between 1996 and 2000: population-based data. BMC Cancer 5: 33, 2005.
3. Database of Deaths National Institute of Statistics (INEGI)/Health Secretariat (SSA), Directorate General of Health Information, Mexico. February, 2006. Available at: www.inegi.org.mx/ Accessed April, 2008.
4. Leil TA, Endo C, Adjei AA, et al: Identification and characterization of genetic variation in the folylpolyglutamate synthase gene. Cancer Res 67: 8772-8782, 2007.
5. Gómez-Gómez Y, Organista-Nava J, Saavedra-Herrera MV, et al: Survival and risk of relapse of acute lymphoblastic leukemia in a Mexican population is affected by dihydrofolate reductase gene polymorphisms. Exp Ther Med 3: 665-672, 2012.
6. Insurance-Popular: Secretary of Health/Seguro Popular. http://www.seguro-popular.gob.mx/. Accessed May, 2009.
7. Leyva-Vázquez MA, Organista-Nava J, Gómez-Gómez Y, et al: Polymorphism G80A in the reduced folate carrier gene and its relationship to survival and risk of relapse in acute lymphoblastic leukemia. J Investig Med 60: 1064-1067, 2012.
8. Merante F, Raha S, Reed J and Proteau G: The Simultaneous Isolation of RNA and DNA from Tissues and Cultured Cells. Methods Mol Biol 58: 3-9, 1996.
9. Organista-Nava J, Gómez-Gómez Y, Saavedra-Herrera MV, et al: Polymorphisms of the gamma-glutamyl hydrolase gene and risk of relapse to acute lymphoblastic leukemia in Mexico. Leuk Res 34: 728-732, 2010.
10. Dulucq S, St-Onge G, Gagné V, et al: DNA variants in the dihydrofolate reductase gene and outcome in childhood ALL. Blood 111: 3692-3700, 2008.
11. Wessels JA, van der Kooij SM, le Cessie S, et al: A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis. Arthritis Rheum 56: 1765-1775, 2007.
12. Lee KM, Lan Q, Kricker A, et al: One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia. Hum Genet 122: 525-533, 2007.
13. Lim U, Wang SS, Hartge P, et al: Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study. Blood 109: 3050-3059, 2007.
14. van der Straaten RJ, Wessels JA, de Vries-Bouwstra JK, et al: Exploratory analysis of four polymorphisms in human GGH and FPGS genes and their effect in methotrexate-treated rheumatoid arthritis patients. Pharmacogenomics 8: 141-150, 2007.